Bone morphogenetic protein-2 in biodegradable gelatin and β-tricalcium phosphate sponges enhances the in vivo bone-forming capability of bone marrow mesenchymal stem cells

Journal of Tissue Engineering and Regenerative Medicine

Volumn 6, Issue 4, 2012, Pages 253-260

  Tadokoro, Mika ^a   Matsushima, Asako ^a   Kotobuki, Noriko ^a   Hirose, Motohiro ^a   Kimura, Yu ^b   Tabata, Yasuhiko ^b   Hattori, Koji ^a   Ohgushi, Hajime ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Bone morphogenetic protein 2 (BMP 2); Controlled drug release; Gelatin; Mesenchymal stem cell; Osteogenesis

Indexed keywords

ALKALINITY; BONE; CELL CULTURE; CELL ENGINEERING; CERAMIC MATERIALS; COMPUTERIZED TOMOGRAPHY; FLOWCHARTING; GENE EXPRESSION; PHOSPHATASES; STEM CELLS; TARGETED DRUG DELIVERY; TISSUE ENGINEERING;

BONE MARROW MESENCHYMAL; BONE MORPHOGENETIC PROTEIN-2; CONTROLLED DRUG RELEASE; GELATIN; MARROW MESENCHYMAL STEM CELLS; MESENCHYMAL STEM CELL; OSTEOGENESIS; OSTEOGENIC DIFFERENTIATION; TRI-CALCIUM PHOSPHATES;

CONTROLLED DRUG DELIVERY;

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; CALCIUM PHOSPHATE CERAMIC; GELATIN SPONGE; OSTEOCALCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIODEGRADABLE IMPLANT; BONE DEVELOPMENT; BONE MARROW MESENCHYMAL STEM CELL; BONE REMODELING; BONE TISSUE; CHEMICAL ANALYSIS; COMPOSITE MATERIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HISTOLOGY; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; RAT; TISSUE ENGINEERING;

EID: 84859422947     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.427     Document Type: Article

References (29)

1. Barrere F, van Blitterswijk CA, de Groot K. 2006; Bone regeneration: molecular and cellular interactions with calcium phosphate ceramics. Int J Nanomed 1: 317-332.
2. Betz VM, Betz OB, Harris MB, et al. 2008; Bone tissue engineering and repair by gene therapy. Front Biosci 13: 833-841.
3. Chan J, O'Donoghue K, De la Fuente J, et al. 2005; Human fetal mesenchymal stem cells as vehicles for gene delivery. Stem Cells 23: 93-102.
4. Giannoudis PV, Dinopoulos H, Tsiridis E. 2005; Bone substitutes: an update. Injury 36: 20-27.
5. Ikeuchi M, Dohi Y, Horiuchi K, et al. 2002; Recombinant human bone morphogenetic protein-2 promotes osteogenesis within atelopeptide type I collagen solution by combination with rat cultured marrow cells. J Biomed Mater Res 60: 61-69.
6. Kawate K, Yajima H, Ohgushi H, et al. 2006; Tissue-engineered approach for the treatment of steroid-induced osteonecrosis of the femoral head: transplantation of autologous mesenchymal stem cells cultured with β-tricalcium phosphate ceramics and free vascularized fibula. Artif Organs 30: 960-962.
7. Kodama N, Nagata M, Tabata Y, et al. 2009; A local bone anabolic effect of rhFGF2-impregnated gelatin hydrogel by promoting cell proliferation and coordinating osteoblastic differentiation. Bone 44: 699-707.
8. LeGeros RZ. 2008; Calcium phosphate-based osteoinductive materials. Chem Rev 108: 4742-4753.
9. Maegawa N, Kawamura K, Hirose M, et al. 2007; Enhancement of osteoblastic differentiation of mesenchymal stromal cells cultured by selective combination of bone morphogenetic protein-2 (BMP-2) and fibroblast growth factor-2 (FGF-2). J Tissue Eng Regen Med 1: 306-313.
10. Maniatopoulos C, Sodek J, Melcher AH. 1988; Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res 254: 317-330.
11. Matsushima A, Kotobuki N, Tadokoro M, et al. 2009; In vivo osteogenic capability of human mesenchymal cells cultured on hydroxyapatite and on β-tricalcium phosphate. Artif Organs 33: 474-481.
12. Morishita T, Honoki K, Ohgushi H, et al. 2006; Tissue engineering approach to the treatment of bone tumors: three cases of cultured bone grafts derived from patients' mesenchymal stem cells. Artif Organs 30: 115-118.
13. Nishikawa M, Myoui A, Ohgushi H, et al. 2004; Bone tissue engineering using novel interconnected porous hydroxyapatite ceramics combined with marrow mesenchymal cells: quantitative and three-dimensional image analysis. Cell Transplant 13: 367-376.
14. Ohgushi H, Caplan AI. 1999; Stem cell technology and bioceramics: from cell to gene engineering. J Biomed Mater Res 48: 913-927.
15. Ohgushi H, Dohi Y, Katuda T, et al. 1996; In vitro bone formation by rat marrow cell culture. J Biomed Mater Res 32: 333-340.
16. Ohgushi H, Kitamura S, Kotobuki N, et al. 2004; Clinical application of marrow mesenchymal stem cells for hard tissue repair. Yonsei Med J 45: 61-67.
17. Ohgushi H, Kotobuki N, Funaoka H, et al. 2005; Tissue engineered ceramic artificial joint-ex vivo osteogenic differentiation of patient mesenchymal cells on total ankle joints for treatment of osteoarthritis. Biomaterials 26: 4654-4661.
18. Okamoto M, Dohi Y, Ohgushi H, et al. 2006; Influence of the porosity of hydroxyapatite ceramics on in vitro and in vivo bone formation by cultured rat bone marrow stromal cells. J Mater Sci Mater Med 17: 327-336.
19. Raiche AT, Puleo DA. 2004; Cell responses to BMP-2 and IGF-I released with different time-dependent profiles. J Biomed Mater Res A 69A: 342-350.
20. Reddi AH, Cunningham NS. 1993; Initiation and promotion of bone differentiation by bone morphogenetic proteins. J Bone Miner Res 8: S499-502.
21. Ruhe PQ, Boerman OC, Russel FGM, et al. 2006; In vivo release of rhBMP-2 loaded porous calcium phosphate cement pretreated with albumin. J Mater Sci Mater Med 17: 919-927.
22. Shimaoka H, Dohi Y, Ohgushi H, et al. 2004; Recombinant growth/differentiation factor-5 (GDF-5) stimulates osteogenic differentiation of marrow mesenchymal stem cells in porous hydroxyapatite ceramic. J Biomed Mater Res A 68A: 168-176.
23. Tabata Y. 2008; Current status of regenerative medical therapy based on drug delivery technology. Reprod Biomed Online 16: 70-80.
24. Tabata Y. 2009; Biomaterial technology for tissue engineering applications. J Roy Soc Interface 6: S311-324.
25. Tabata Y, Nagano A, Ikada Y. 1999; Biodegradation of hydrogel carrier incorporating fibroblast growth factor. Tissue Eng 5: 127-138.
26. Takahashi Y, Yamamoto M, Tabata Y. 2005a; Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and β-tricalcium phosphate. Biomaterials 26: 4856-4865.
27. Takahashi Y, Yamamoto M, Tabata Y. 2005b; Osteogenic differentiation of mesenchymal stem cells in biodegradable sponges composed of gelatin and β-tricalcium phosphate. Biomaterials 26: 3587-3596.
28. Yoshikawa H, Myoui A. 2005; Bone tissue engineering with porous hydroxyapatite ceramics. J Artif Organs 8: 131-136.
29. Zegzula HD, Buck DC, Brekke J, et al. 1997; Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2). J Bone Joint Surg Am 79A: 1778-1790.